Steffen Lawo

Head of CRISPR Screening Core Facility

Max Planck Institute for Biology of Ageing
Country flagGermany

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Articles (8)

Year:

2026

To maintain cellular homeostasis, protein quality control (PQC) machineries target damaged proteins for degradation. However, the PQC machinery, operating at the major protein sorting and processing site of mammalian cells, the Golgi, has remained largely elusive. Here we used a chemical biology tool to induce misfolding and ubiquitination of Golgi-localized model substrates. Our tool recruits a Cullin-RING ubiquitin ligase complex by exposure of a degron, recognized by the substrate receptor KLHDC2. Using this tool, we found that ubiquitinated Golgi membrane proteins are targeted for proteasomal degradation, a process that is critical to avoid Golgi fragmentation. This process is facilitated by the p97-unfoldase, which assembles with its adaptors UFD1-NPL4 and FAF2 at the Golgi. We further identified the rhomboid pseudo-protease RHBDD2 as an important contributor to Golgi homeostasis as it binds misfolded, ubiquitinated Golgi membrane proteins and regulates Golgi morphology. Our findings establish a molecular framework for Golgi-PQC in mammalian cells. The accumulation of misfolded Golgi proteins causes Golgi fragmentation. Ubiquitinated Golgi membrane proteins are degraded by the proteasome. The p97 unfoldase operates at the Golgi with its adaptors UFD1-NPL4 and FAF2. The rhomboid pseudo-protease RHBDD2 contributes to Golgi protein quality control.

Year:

2026

Year:

2025

Membrane contact sites (MCS) are essential for organelle communication in eukaryotic cells. Pathogens also establish MCS with host organelles, but the mechanisms underlying these interactions and their role in infection remain poorly understood. Here, using a fluorescence sensor and CRISPR-based loss-of-function screening, together with imaging and proteomics, we identify the parasite effector mediating MCS between host endoplasmic reticulum (ER) and the vacuole containing the intracellular parasite Toxoplasma gondii . TgROP1 acts as a tether and mimics a canonical FFAT motif to bind the host ER proteins VAPA and VAPB. The loss of VAPA/B abolished host ER– Toxoplasma MCS and decreased pathogen growth. These findings indicate that targeting of host MCS tethers is a strategy exploited by pathogens during infection, which could inform future treatment design.

Year:

2025

At least 40% of human cancers are associated with aberrant ERK pathway activity (ERKp). Inhibitors targeting various effectors within the ERKp have been developed and explored for over two decades. Conversely, a substantial body of evidence suggests that both normal human cells and, notably to a greater extent, cancer cells exhibit susceptibility to hyperactivation of ERKp. However, this vulnerability of cancer cells remains relatively unexplored. In this review, we reexamine the evidence on the selective lethality of highly elevated ERKp activity in human cancer cells of varying backgrounds. We synthesize the insights proposed for harnessing this vulnerability of ERK-associated cancers for therapeutical approaches and contextualize these insights within established pharmacological cancer-targeting models. Moreover, we compile the intriguing preclinical findings of ERK pathway agonism in diverse cancer models. Lastly, we present a conceptual framework for target discovery regarding ERKp agonism, emphasizing the utilization of mutual exclusivity among oncogenes to develop novel targeted therapies for precision oncology.

Year:

2024

Year:

2023

Year:

2020

Year:

2020

Collaborators (6)

Doris Hellerschmied

Associate Professor (W2)

ZMB - Center of Medical Biotechnology, University Duisburg-Essen

GERMANY
View details

Farnusch Kaschani

Head of Analytics Core Facility Essen

Universität Duisburg-Essen

GERMANY
View details

Sofia Ahola

Assistant Professor

University of Birmingham

UNITED KINGDOM
View details

Moritz Treeck

Senior Group Leader

Instituto Gulbenkian de Ciência

PORTUGAL
View details

Soni Deshwal

Group Leader-ERC starting grantee

Helmholtz Zentrum München Deutsches Forschungszentrum für Umwelt und Gesundheit

GERMANY
View details

Markus Kaiser

Universität Duisburg-Essen

GERMANY
View details